New Diabetes Drug Approved for Once a Week Dosage

.

New Diabetes Drug Approved for Once a Week Dosage

It has been recently revealed in a report that the new proposal of Amylin Pharmaceutical company for a more convenient and novel type of diabetes drug has been approved by the Food and Drug Administration. This shall now give way for a new type of Type 2 diabetes drug, which can be conveniently registered to people merely once a week and this would be able to give the people a better control over their disease and they would be able to live life happily and without any fears.

The name of the drug is Byudereon and this will be able to provide help to people suffering from diabetes, only by being administered once a week. There is a competitor drug for the same being developed by Novo Nordisk medical firm, and the name of this drug is Victoza, which shall also be injected once a day.

It has also been rumored that the celebrity chef Paula Deen is going to be the ambassador for their drug, who has apparently recently been diagnosed of diabetes herself.

"Think for a moment how much easier their lives would be by taking a drug just once a week, a drug that offers solid glucose control, does not require glucose monitoring and comes with added benefit of weight loss", revealed David Kliff, publisher of Diabetic Investor.

There is need for the patients of the disease to stay focused on maintaining a healthy life, with good habits of food and exercise. This alone can let them lead a healthy and balanced life, with no types of physical problems ahead of them. People with diabetes need to restrict and control their eating habits, in order to maintain the balance.


Latest News

Tesla Battery May Help Consumers Save Twenty Five Percent on Electric Bills
Some American Airlines Flights Delayed due to iPad app Issue
Raising Retirement Age could Benefit Social Security According to Christie
Apigee Becomes the Second Tech Company for Silicon Valley to go Public this Year
Massive Crane Begins its First lift Helping to Build the Tappan Zee Bridge
Shares of Facebook Drop as the Social Networking Company Fails to Match Expectat
First Quarter Profits of Discover Financial Services Drops but Surpasses Analyst
Amgen Inc. Announced First Quarter Earnings that Beat Analysts’ Expectations and
Magnificent, Perfect100-carat Diamond Sells for $22Millon in Sotheby’s Jewelry A
Kraft Revamping Its Iconic Macaroni and Cheese Meal by Removing Synthetic Colour
San Juan Capistrano’s Tiered Rates for Water-Use Thrown Out by Appeals Court
Morgan Stanley Announces Better than Expected First Quarter Profits